Canaccord Genuity Group Issues Positive Forecast for Nature's Sunshine Products (NASDAQ:NATR) Stock Price

Key Points

• Canaccord Genuity Group has raised its target price for **Nature's Sunshine Products** (NASDAQ:NATR) from **$21.00 to $22.00**, indicating a potential upside of **39.24%** from the stock's previous close.
• Shares of Nature's Sunshine experienced a **12.8% increase**, trading at **$15.80**, with a market cap of **$291.67 million** and recent earnings of **$0.35 per share**, surpassing analysts' estimates.
• Major shareholder **Fosun Pharmaceutical Shanghai** sold over **2.8 million shares** at an average price of **$11.46**, while 79.40% of the stock is currently owned by institutional investors.

Nature's Sunshine Products (NASDAQ:NATR - Get Free Report) had its price target hoisted by equities research analysts at Canaccord Genuity Group from $21.00 to $22.00 in a research note issued to investors on Friday,Benzinga reports. The brokerage currently has a "buy" rating on the stock. Canaccord Genuity Group's price target points to a potential upside of 44.12% from the company's current price.

Separately, DA Davidson reiterated a "buy" rating and issued a $19.00 target price on shares of Nature's Sunshine Products in a research note on Tuesday, June 3rd.

Nature's Sunshine Products Price Performance

NATR traded down $0.24 during midday trading on Friday, hitting $15.27. 18,556 shares of the company's stock traded hands, compared to its average volume of 58,908. The company has a market cap of $269.27 million, a PE ratio of 20.63 and a beta of 1.14. The stock's fifty day simple moving average is $14.91 and its 200-day simple moving average is $13.95. Nature's Sunshine Products has a one year low of $10.81 and a one year high of $18.06.

Nature's Sunshine Products (NASDAQ:NATR - Get Free Report) last released its quarterly earnings data on Thursday, July 31st. The company reported $0.35 EPS for the quarter, topping analysts' consensus estimates of $0.16 by $0.19. Nature's Sunshine Products had a net margin of 3.06% and a return on equity of 10.19%. The company had revenue of $114.75 million during the quarter, compared to the consensus estimate of $113.10 million.

Insiders Place Their Bets

In other news, major shareholder Fosun Pharmaceutical Shanghai sold 2,854,607 shares of Nature's Sunshine Products stock in a transaction that occurred on Friday, June 27th. The shares were sold at an average price of $11.46, for a total value of $32,713,796.22. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders own 5.60% of the company's stock.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the business. American Century Companies Inc. increased its stake in shares of Nature's Sunshine Products by 2.7% during the fourth quarter. American Century Companies Inc. now owns 304,432 shares of the company's stock worth $4,463,000 after purchasing an additional 8,085 shares during the period. JPMorgan Chase & Co. increased its stake in shares of Nature's Sunshine Products by 74.0% during the fourth quarter. JPMorgan Chase & Co. now owns 60,277 shares of the company's stock worth $884,000 after purchasing an additional 25,644 shares during the period. Wells Fargo & Company MN increased its stake in shares of Nature's Sunshine Products by 28.8% during the fourth quarter. Wells Fargo & Company MN now owns 7,209 shares of the company's stock worth $106,000 after purchasing an additional 1,611 shares during the period. Russell Investments Group Ltd. bought a new position in shares of Nature's Sunshine Products during the fourth quarter worth approximately $41,000. Finally, Renaissance Technologies LLC increased its stake in shares of Nature's Sunshine Products by 3.6% during the fourth quarter. Renaissance Technologies LLC now owns 542,297 shares of the company's stock worth $7,950,000 after purchasing an additional 18,800 shares during the period. 79.40% of the stock is currently owned by institutional investors.

About Nature's Sunshine Products

Nature's Sunshine Products, Inc, a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision.